Journal of Antimicrobial Chemotherapy (2001) 47, 147-152
© 2001 The British Society for Antimicrobial Chemotherapy
Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila
National Reference Centre of Hygiene and Institute of Environmental Medicine and Hospital Epidemiology, Freiburg University Hospital, Hugstetter Strasse 55, D-79106 Freiburg, Germany
This study compares the in vitro activity of novel fluoroquinolones against clinical Legionella pneumophila isolates. We determined both the MICs and intracellular efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin in the Mono Mac 6 infection model. Six legionella strains were tested and all proved highly susceptible to the fluoroquinolones. Clinafloxacin and trovafloxacin were found to have the lowest MICs (0.004 mg/L) followed by levofloxacin and moxifloxacin (0.015–0.03 mg/L). In the Mono Mac 6 infection model, inhibition of L. pneumophila was achieved at concentrations four times below the respective in vitro MICs. Concentrations as low as 0.015 mg/L of moxifloxacin and levofloxacin, 0.004 mg/L of trovafloxacin and 0.002 mg/L of clinafloxacin markedly decreased viable intracellular bacterial counts. These data strongly support further clinical evaluation of new fluoroquinolones for empirical treatment of lower respiratory tract infection including atypical pneumonia caused by L. pneumophila.
* Corresponding author. Tel: +49-761-270-5445; Fax: +49-761-270-5485; E-mail: djonas{at}IUK3.UKL.uni-Freiburg.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Almahmoud, E. Kay, D. Schneider, and M. Maurin Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila J. Antimicrob. Chemother., August 1, 2009; 64(2): 284 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Valderas and W. W. Barrow Establishment of a method for evaluating intracellular antibiotic efficacy in Brucella abortus-infected Mono Mac 6 monocytes J. Antimicrob. Chemother., January 1, 2008; 61(1): 128 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tano, O. Cars, and E. Lowdin Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model J. Antimicrob. Chemother., July 1, 2005; 56(1): 240 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Roch and M. Maurin Antibiotic susceptibilities of Legionella pneumophila strain Paris in THP-1 cells as determined by real-time PCR assay J. Antimicrob. Chemother., June 1, 2005; 55(6): 866 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Seral, M. Barcia-Macay, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages J. Antimicrob. Chemother., April 1, 2005; 55(4): 511 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Furlanut, L. Brollo, E. Lugatti, E. Di Qual, F. Dolcet, G. Talmassons, and F. Pea Pharmacokinetic aspects of levofloxacin 500 mg once daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections J. Antimicrob. Chemother., January 1, 2003; 51(1): 101 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Paillard, J. Grellet, V. Dubois, M.-C. Saux, and C. Quentin Discrepancy between Uptake and Intracellular Activity of Moxifloxacin in a Staphylococcus aureus-Human THP-1 Monocytic Cell Model Antimicrob. Agents Chemother., February 1, 2002; 46(2): 288 - 293. [Abstract] [Full Text] [PDF]
|
|